Exogenous stem cell factor (SCF) compensates for altered endogenous SCF expression in 2,5-hexanedione-induced testicular atrophy in rats. 1996

E K Allard, and K T Blanchard, and K Boekelheide
Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island 02912, USA.

2,5-Hexanedione (2,5-HD) is a Sertoli cell toxicant that causes irreversible testicular atrophy in rats. After toxicant exposure, only Sertoli cells, stem cells, and a few committed type A spermatogonia remain in the seminiferous epithelium. A majority of the stem cell progeny differentiate into type A spermatogonia, but then, rather than continuing to differentiate, undergo apoptosis. We hypothesized that the cause for germ cell apoptosis was, at least in part, a deficiency in the function of stem cell factor (SCF), a paracrine growth factor normally made by Sertoli cells. To test this hypothesis, rats were exposed to 1% 2,5-HD for 5 wk and killed at various times after toxicant exposure. Northern blot analysis and reverse transcription-polymerase chain reaction (RT-PCR) were used to determine that, unlike what was observed in control testes, the majority of SCF was expressed in the soluble form after 2,5-HD injury. In vitro co-culture experiments were used to establish the appropriate dose of SCF to administer in vivo. A continuous intratesticular delivery system was established and used to expose 2,5-HD-treated rats to SCF for 2 wk. Animals were exposed to bromodeoxycytidine (BrdCyd) for 2 days before being killed in order to assess the effect of SCF on germ cell proliferation. SCF caused a statistically significant increase in the number of germ cells positive for bromodeoxyuridine (BrdUrd), indicating that SCF promoted survival and/or stimulated proliferation of the remaining germ cells. We conclude that SCF expression is disrupted after 2,5-HD-induced testicular atrophy and that exogenous administration of SCF promotes recovery of spermatogenesis.

UI MeSH Term Description Entries
D008297 Male Males
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006588 Hexanones 6-carbon straight-chain or branched ketones. Butyl Methyl Ketones,Ethyl Propyl Ketones,Ketones, Butyl Methyl,Ketones, Ethyl Propyl,Methyl Ketones, Butyl,Propyl Ketones, Ethyl
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001284 Atrophy Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes. Atrophies
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013094 Spermatozoa Mature male germ cells derived from SPERMATIDS. As spermatids move toward the lumen of the SEMINIFEROUS TUBULES, they undergo extensive structural changes including the loss of cytoplasm, condensation of CHROMATIN into the SPERM HEAD, formation of the ACROSOME cap, the SPERM MIDPIECE and the SPERM TAIL that provides motility. Sperm,Spermatozoon,X-Bearing Sperm,X-Chromosome-Bearing Sperm,Y-Bearing Sperm,Y-Chromosome-Bearing Sperm,Sperm, X-Bearing,Sperm, X-Chromosome-Bearing,Sperm, Y-Bearing,Sperm, Y-Chromosome-Bearing,Sperms, X-Bearing,Sperms, X-Chromosome-Bearing,Sperms, Y-Bearing,Sperms, Y-Chromosome-Bearing,X Bearing Sperm,X Chromosome Bearing Sperm,X-Bearing Sperms,X-Chromosome-Bearing Sperms,Y Bearing Sperm,Y Chromosome Bearing Sperm,Y-Bearing Sperms,Y-Chromosome-Bearing Sperms
D013733 Testicular Diseases Pathological processes of the TESTIS. Disease, Testicular,Diseases, Testicular,Testicular Disease

Related Publications

E K Allard, and K T Blanchard, and K Boekelheide
June 1981, Toxicology and applied pharmacology,
E K Allard, and K T Blanchard, and K Boekelheide
January 2003, Annual review of pharmacology and toxicology,
E K Allard, and K T Blanchard, and K Boekelheide
April 2008, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban,
E K Allard, and K T Blanchard, and K Boekelheide
January 1993, International archives of occupational and environmental health,
E K Allard, and K T Blanchard, and K Boekelheide
April 1983, Experimental and molecular pathology,
E K Allard, and K T Blanchard, and K Boekelheide
April 1996, Toxicology and applied pharmacology,
E K Allard, and K T Blanchard, and K Boekelheide
August 1995, Pharmacology & toxicology,
E K Allard, and K T Blanchard, and K Boekelheide
July 1995, Biology of reproduction,
E K Allard, and K T Blanchard, and K Boekelheide
July 2010, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!